Clinical trial Recruiting at 1 site Observational Ages 18 to 75

Monitoring the performance of hip implants after surgery

Official title: Everglade Stem, World Cup and World Liner Post Market Clinical Follow-up

Run by Signature Orthopaedics · NCT06153940 · Data updated 2026-11-12

This study looks at how well certain hip implants work and how happy patients are with them after hip surgery over a couple of years.

Quick facts

Study typeObservational
Ages18 Years to 75 Years
SexAll
Enrollment200 (estimated)
SponsorSignature Orthopaedics
Industry-sponsored
Locations1 site (Cleveland, Ohio)
StatusRecruiting
StartedNovember 22, 2023
Main results expectedMarch 1, 2028
Study endsMarch 1, 2028
Registry record updatedDecember 1, 2023
Trial IDNCT06153940 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18-75 requiring unilateral primary total hip arthroplasty due to non-inflammatory degenerative joint diseases.

Probably not a fit

Patients with active infections, inadequate bone stock, known metal sensitivities, or those who are immuno-suppressed may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to collect data on the safety and performance of the Everglade Stem, World Acetabular Cup, and World Liner used in primary total hip arthroplasty. It involves a prospective follow-up of patients at various time points, including pre-operative, discharge, one year, and two years post-operative evaluations. The primary objective is to monitor the revision rate of the implants and assess patient satisfaction through the Oxford Hip Score, alongside radiographic analysis to evaluate the effectiveness of cementless fixation.

Why it matters

Potential benefit: If successful, this study could provide valuable insights into the long-term safety and effectiveness of these hip implants, potentially improving patient outcomes.

How similar studies have gone: Other studies on post-market clinical follow-up of orthopedic implants have shown success in confirming safety and performance, making this approach well-supported.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* patient requires unilateral primary total hip arthroplasty due to non-inflammatory degenerative joint disease (e.g. osteoarthritis, traumatic arthritis, avascular necrosis, dysplasia/DDH)
* patient must be a candidate for use of the products studied, as determined jointly by the surgeon and patient
* male and non-pregnant female patients aged 18-75
* patients who understand the conditions of the clinical evaluation and are willing to participate for the length of the prescribed follow-up

Exclusion Criteria:

* patient has active infection or sepsis(treated or untreated) enough to compromise implant stability or postoperative recovery
* patient is a female of child-bearing age and not taking and not taking contraceptive pills
* patient has inadequate bone stock to support the device (e.g. severe osteopenia, family history of severe osteoporosis or osteopenia)
* patient has a known or suspected metal sensitivity
* patient is immuno-suppressed with disease such as AIDS or is receiving high dose of cortico-steroids.
* patient has an emotional or neurological condition that would pre-empt their ability or unwillingness to participate in the clinical evaluation including mental illness, mental retardation or drug abuse
* patient is severely overweight with a BMI\>40.

Where it's running

  • Cleveland Clinic
    Cleveland, Ohio, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.